Hikari Tsushin Inc. increased its stake in Danaher Corporation (NYSE:DHR) by 8.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 65,135 shares of the conglomerate’s stock after purchasing an additional 5,300 shares during the period. Danaher Corporation accounts for 1.7% of Hikari Tsushin Inc.’s portfolio, making the stock its 8th largest holding. Hikari Tsushin Inc.’s holdings in Danaher Corporation were worth $5,497,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of DHR. GQG Partners LLC bought a new position in Danaher Corporation in the 2nd quarter worth approximately $101,000. Proficio Capital Partners LLC grew its holdings in Danaher Corporation by 92.3% during the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 598 shares during the period. Monetary Management Group Inc. grew its holdings in Danaher Corporation by 10.7% during the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after acquiring an additional 150 shares during the period. Acrospire Investment Management LLC grew its holdings in Danaher Corporation by 185.5% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after acquiring an additional 1,100 shares during the period. Finally, ClariVest Asset Management LLC acquired a new stake in Danaher Corporation during the 1st quarter worth $157,000. Hedge funds and other institutional investors own 75.61% of the company’s stock.

Danaher Corporation (DHR) opened at $92.62 on Tuesday. The firm has a market cap of $64,778.23, a price-to-earnings ratio of 23.94, a P/E/G ratio of 2.21 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. Danaher Corporation has a one year low of $76.27 and a one year high of $93.16.

Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.05. The firm had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.87 EPS. analysts predict that Danaher Corporation will post 3.99 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Friday, September 29th were paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend was Thursday, September 28th. Danaher Corporation’s payout ratio is presently 16.52%.

In related news, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction on Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total value of $960,693.96. Following the completion of the transaction, the director now directly owns 104,621 shares of the company’s stock, valued at approximately $9,501,679.22. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider William King sold 43,688 shares of the company’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the transaction, the insider now directly owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 279,628 shares of company stock valued at $25,304,394. Company insiders own 12.20% of the company’s stock.

A number of analysts have commented on DHR shares. J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $95.00 target price on shares of Danaher Corporation in a report on Friday, September 8th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a report on Thursday, October 5th. Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the stock a “buy” rating in a report on Friday, July 21st. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $95.00 target price (up previously from $86.00) on shares of Danaher Corporation in a report on Friday, October 6th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $93.31.

TRADEMARK VIOLATION WARNING: “Danaher Corporation (DHR) Holdings Lifted by Hikari Tsushin Inc.” was reported by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/danaher-corporation-dhr-holdings-lifted-by-hikari-tsushin-inc/1685005.html.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.